- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07935603
Aural Rehab for Adult CI Outcomes
A Phase I, Single-Center Study of the Effects of Aural Rehabilitation Protocols on Adult Cochlear Implant Outcomes
This study will compare two different types of aural rehabilitation schedules (computer-based auditory training vs computer based auditory training and clinician guided training) for adult cochlear implant (CI) users to determine the effect of rehabilitation type on speech perception, hearing related-quality of life, and CI management skills.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: J. Thomas Roland, Jr., MD
- Numero di telefono: 212-263-5565
- Email: J.Thomas.RolandJr@nyulangone.org
Luoghi di studio
-
-
New York
-
New York, New York, Stati Uniti, 10016
- NYU Langone Heath
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Be at least 18 years of age at the time of cochlear implantation.
- Receive pre- and post-CI care at the NYU Langone Health Cochlear Implant Center.
- Have bilateral hearing loss, with at least moderate to profound hearing loss in both ears.
- Be able to participate in follow-up visits, either in person or via synchronous telehealth, and to use an app-based training platform (ReDi).
- Be English-speaking or have native-like English proficiency.
Exclusion Criteria:
- Has significant cognitive impairment or a medical disability that precludes informed consent or reliable participation or develops such impairment during the study period.
- Has pre-lingual or long-term (>20 years) severe to profound hearing loss
- Is undergoing cochlear implantation for single-sided deafness.
- Is undergoing revision CI surgery.
- Is younger than 18 years of age.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Computer-Based Auditory Training
CI users assigned to receive computer-based auditory training only. |
Aural rehabilitation program delivered through an auditory training app. Each participant will be assigned to complete training 5 days per week, with each session being 15 minutes for the first 6 months post-activation. |
|
Sperimentale: Computer-Based Auditory Training + Clinician-Guided Training
CI users assigned to receive computer-based auditory training and clinician-guided training. |
Aural rehabilitation program delivered through an auditory training app. Each participant will be assigned to complete training 5 days per week, with each session being 15 minutes for the first 6 months post-activation. Aural rehabilitation program delivered by a speech-language pathologist. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in CNC Word Recognition Score
Lasso di tempo: Baseline (pre-cochlear implant), Year 1 Post-Activation
|
Calculated as the percentage of words a person can hear, repeat back, and understand. |
Baseline (pre-cochlear implant), Year 1 Post-Activation
|
|
Change in CNC Phoneme Recognition Score
Lasso di tempo: Baseline (pre-cochlear implant), Year 1 Post-Activation
|
Calculated as the percentage of individual phonemes (sounds) identified correctly out of 150 total phonemes. |
Baseline (pre-cochlear implant), Year 1 Post-Activation
|
|
Change in AzBio Sentence Recognition Score
Lasso di tempo: Baseline (pre-cochlear implant), Year 1 Post-Activation
|
Standardized speech perception assessment used by audiologists to measure how well a person understands everyday conversational speech. Patients are evaluated on their ability to recognize words correctly in a sentence. Each sentence has a set number of key words assigned specific point values. The final score is calculated as a percentage of words correct out of the total possible words in the list. |
Baseline (pre-cochlear implant), Year 1 Post-Activation
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in CIQOL35 Profile Score
Lasso di tempo: Week 6 Post-Activation, Year 1 Post-Activation
|
Patient-reported outcome measure designed to evaluate real-world functional abilities and quality of life for adult cochlear implant (CI) users. Each item is rated on a Likert scale; the raw score is re-scaled into a total score from 0 (low quality of life/functional ability) to 100 (high quality of life/functional ability). |
Week 6 Post-Activation, Year 1 Post-Activation
|
|
Change in CIMS-Self
Lasso di tempo: Week 6 Post-Activation, Year 1 Post-Activation
|
10-item self-administered assessment of how effectively a patient or caregiver handles and maintains a cochlear implant processor. Each response is rated from 0 to 3; the raw score is the sum of responses and is transformed to a percentage (0 - 100%); a score below 100% indicates a need for targeted training or retraining in specific maintenance areas. |
Week 6 Post-Activation, Year 1 Post-Activation
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: J. Thomas Roland, Jr., MD, NYU Langone Health
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 26-00880
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
No plan to make IPD available.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .